Michael McGrady is a journalist and researcher covering alternative nicotine products and tobacco harm reduction. His work has appeared in the Wall Street Journal, the Hill and the South China Morning Post.
Cinzia holds a degree in law and criminology. She has developed specific expertise on European policies, advocacy and networking on harm reduction in the criminal justice system. Within this sector she has coordinated research, organised events, trainings and capacity building initiatives, thus bridging expertise between civil society and the institutional sector.
Professor Nick Crofts is an epidemiologist and public health practitioner who has been working in the fields of HIV/AIDS, illicit drugs, harm reduction and law enforcement for over 30 years. His major epidemiological work has been on the control of HIV and hepatitis C among injecting drug users in Australia (for which he received an NHMRC Senior Research Fellowship) and globally, including almost every country in Asia, for which he received the International Rolleston Award from the International Harm Reduction Association in 1998.
Works in drug policy and human rights fields. For the last decade, she has worked with the Global Drug Policy Program of the Open Society Foundations (currently as a consultant in Poland where she is based) as well as with a number of other Polish and international NGOs (including Helsinki Foundation for Human Rights in Warsaw and AFEW International).
Dr Marewa Glover (Director) is an indigenous behavioral scientist who has worked on reducing harms from smoking for over 25 years. She has over 100 scientific publications, has been involved in many trials and has led many research projects. Reducing smoking among pregnant Māori women has been a particular focus of her research.
Professor Jim McVeigh Substance Use and Associated Behaviours Group Department of Sociology Manchester Metropolitan University. Jim's main research area is human enhancement drug use, in particular, anabolic steroids and associated drugs. He also interested in the wider issues associated with all forms of substance use. Jim’s commitment to public health continues and he remain passionate about addressing health inequalities and social deprivation.
Ethan A. Nadelmann is the founder of the Drug Policy Alliance, a New York City-based non-profit organization working to end the War on Drugs. Described by Rolling Stone as "the point man" for drug policy reform efforts and “the real drug czar,” Ethan Nadelmann is widely regarded as the outstanding proponent of drug policy reform both in the United States and abroad.
David Sweanor is an adjunct professor, Faculty of Law, and chair of the advisory board of the Centre for Health Law, Policy & Ethics at the University of Ottawa and has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked globally, and with numerous groups, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization and played a key role in achieving many global precedents in tobacco policy. He currently focuses much of his tobacco and nicotine related efforts on risk reduction strategies.
Dr Hannah Timpson is Head of Research Engagement and Impact at the Public Health Institute, LJMU. Hannah’s role involves leading and developing the research and related activity that encompasses community engagement, local impact and social value. This programme of research involves partnership working with commissioners and service providers within organisations such as local authorities, health and social care services and the third sector to provide responsive support, identify research priorities and deliver research which has direct application back into practice. The research uses a range of methodologies to capture qualitative and quantitative evidence of outcomes and impact.
Dr Alex Wodak AM is a retired physician who is now President of the Australian Drug Law Reform Foundation. he works full time on drug law reform as a volunteer. Together with colleagues, he started the first needle syringe programme (1986) and the first medically supervised injecting centre (1999) in Australia when both were pre-legal. Dr Wodak was President of the International Harm Reduction Association (1996-2004). He has been interested in tobacco harm reduction since 1992 but only active in THR in recent years. Dr Wodak helped to start the National Drug and Alcohol Research Centre (1987).